05/10/2006
Consultation on draft guidance for non-commercial clinical trials
DG Enterprise and Industry has released ‘Draft guidance on ‘specific modalities’ for non-commercial clinical trials referred to in Commission Directive 2005/28/EC laying down the principles and detailed guidelines for good clinical practice’.
This guidance includes information regarding the definition of non-commercial clinical trials and the specific modalities, labelling and documentation, concerning the investigational medicinal product.
DG Enterprise and Industry has also been considering the issue of the monitoring of non-commercial clinical trials. However, specific modalities on monitoring have not been included in this draft guidance since they would go beyond the provisions of Directive 2005/28/EC.
Nevertheless, if stakeholders want to make comments or proposals in relation to the monitoring of non-commercial clinical trials, they are welcome to do so in the framework of this consultation.
More information here
DG Enterprise and Industry has also been considering the issue of the monitoring of non-commercial clinical trials. However, specific modalities on monitoring have not been included in this draft guidance since they would go beyond the provisions of Directive 2005/28/EC.
Nevertheless, if stakeholders want to make comments or proposals in relation to the monitoring of non-commercial clinical trials, they are welcome to do so in the framework of this consultation.
More information here
